잠시만 기다려 주세요. 로딩중입니다.

국내 2018년 의약품 소비량 및 판매액 통계 산출 및 국제 비교

A Critical Evaluation and International Comparison of Pharmaceutical Consumption and Sales Statistics

보건행정학회지 2020년 30권 3호 p.311 ~ 325
김지혜, 김지혜, 이다희, 김수연, 김동숙, 이다희, 김수연, 김동숙,
소속 상세정보
김지혜 ( Kim Ji-Hye ) - Health Insurance Review & Assessment Service Department of Research
이다희 ( Lee Da-Hee ) - Health Insurance Review & Assessment Service Department of Research
김수연 ( Kim Soo-Yon ) - Health Insurance Review & Assessment Service Department of Research
김동숙 ( Kim Dong-Sook ) - Health Insurance Review & Assessment Service Department of Research
이다희 ( Lee Da-Hee ) - Health Insurance Review & Assessment Service Department of Research
김수연 ( Kim Soo-Yon ) - Health Insurance Review & Assessment Service Department of Research
김동숙 ( Kim Dong-Sook ) - Health Insurance Review & Assessment Service Department of Research

Abstract


Background: Health statistics of pharmaceutical use and expenditure are essential to make and implement evidence-based pharmaceutical policy. This study aims to demonstrate the methods and results of pharmaceutical consumption and sales in 2018 according to the sources and methods given by the Organization for Economic Cooperation and Development (OECD).

Methods: The medication list contains 39,346 medicines both reimbursed and non-reimbursed by the National Health Insurance in 2018. We used the therapeutic categories based on Anatomic Therapeutic Chemical Classification of World Health Organization. This study analyzed National Health Insurance claims data and supply data generated from wholesalers to health care facilities. The indicators are defined daily dose (DDD), per 1,000 inhabitants per day and US$ per capita.

Results: In South Korea, the number of medications to which DDD were assigned was 18,055 and it was 45.9% of the total number of medications on the list. The consumption in anti-infective for systemic use (J) and musculo-skeletal system (M) was higher than the mean consumption among the OECD countries. The pharmaceutical sales per person in Korea was also higher than the mean sales per person across the OECD countries.

Conclusion: We sought to explain the methods to produce pharmaceutical consumption and sales statistics which we had submitted annually to OECD. Considering the characteristics of pharmaceutical statistics, a direct comparison should be approached with caution. Since the growth in pharmaceutical spending has greatly increased over the past decade, we need to monitor pharmaceutical consumption and expenditure consistently.

키워드

Drug utilization review; Statistics; Pharmaceutical expen

원문 및 링크아웃 정보

 

등재저널 정보